{"gene":"TWSG1","run_date":"2026-06-10T10:51:56","timeline":{"discoveries":[{"year":2009,"finding":"TWSG1 suppresses hepcidin expression in human hepatocyte cells by inhibiting BMP2/BMP4 signaling (indirect mechanism), and in murine hepatocytes it suppresses hepcidin even in the absence of exogenous BMP, suggesting an additional direct mechanism. Dose-dependent inhibition was demonstrated across 1–1000 ng/mL TWSG1.","method":"Hepcidin suppression assays (quantitative PCR), dosed treatment of hepatocyte cells with recombinant TWSG1 protein, in vivo expression analysis in thalassemic mice","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based functional assay with dose-response and in vivo corroboration, single lab but two orthogonal systems (human vs. murine cells)","pmids":["19414861"],"is_preprint":false},{"year":2009,"finding":"TWSG1 interferes with BMP-mediated hepcidin upregulation by binding to/antagonizing BMP2 and BMP4 ligands, placing TWSG1 upstream of BMP signaling in the hepcidin regulation pathway.","method":"Hepcidin suppression assays with BMP2/BMP4 stimulation and TWSG1 co-treatment, quantitative PCR readout","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional cell-based assay with defined ligand-antagonism readout, single lab","pmids":["19414861"],"is_preprint":false},{"year":2014,"finding":"Loss of Twsg1 (a BMP antagonist) sensitizes mouse embryos to retinoic acid-induced holoprosencephaly; in P19 cells, retinoic acid induces Bmp2 expression and acts synergistically with BMP2 to increase p53 expression, caspase activation, and oxidative stress, suggesting TWSG1 normally restrains BMP2 signaling to protect forebrain development.","method":"Genetic mouse model (Twsg1+/- and Twsg1-/- dams gavaged with RA), embryo microscopy, geometric morphometric micro-CT analysis, P19 cell culture with RA and BMP2 co-treatment, caspase activation and p53 immunoassays","journal":"Disease models & mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined developmental phenotype plus cell-based mechanistic follow-up, single lab","pmids":["25468951"],"is_preprint":false},{"year":2021,"finding":"TWSG1 alone can directly inhibit BMP6 and BMP7 signaling in bioactivity assays. Additionally, TWSG1 enhances the antagonizing ability of Chordin (CHRD) against BMP2, BMP4, BMP7, and GDF5, and enhances CHRDL1 antagonism against BMP2, BMP4, GDF5, and activin A, demonstrating that TWSG1 can act as both an independent BMP antagonist and a co-antagonist synergizing with the chordin subfamily.","method":"Bioactivity assays measuring BMP/TGF-β signaling inhibition in cell-based reporter systems, quantitative PCR expression profiling in rat and human ovarian tissue","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional bioactivity assays with multiple BMP ligands and chordin family members, single lab","pmids":["34517078"],"is_preprint":false},{"year":2022,"finding":"TWSG1 is described as acting as both a BMP agonist and antagonist: it inhibits BMP signaling by binding directly to BMP ligands (including BMP4), while it can enhance BMP signaling by interacting with Chordin (a BMP antagonist), thereby neutralizing Chordin's inhibitory effect.","method":"Literature synthesis with supporting experimental references (review article citing prior binding and functional assay data)","journal":"International journal of molecular sciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — review article summarizing prior experimental results without presenting new primary data; no new experiment described","pmids":["36361543"],"is_preprint":false},{"year":2018,"finding":"TWSG1 overexpression in gastric cancer cell lines (SGC-7901 and MGC-803) inhibited cell cycle progression and proliferation via regulation of BMP signaling, whereas in BGC-823 cells the anti-proliferative effect was independent of BMP signaling, indicating context-dependent mechanisms.","method":"CCK-8 proliferation assay, flow cytometry cell cycle analysis, western blotting for BMP pathway components in gastric cancer cell lines with TWSG1 overexpression","journal":"DNA and cell biology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, overexpression with cell-based readout, limited mechanistic depth on BMP pathway components","pmids":["29756996"],"is_preprint":false},{"year":2024,"finding":"Silencing TWSG1 in A172 glioma cells decreased cell viability, migration, and invasion in vitro and reduced tumor growth in vivo; it also reduced MMP2 and MMP9 expression, and shifted macrophage polarization from M2 toward M1 phenotype both in cell culture and tumor tissue.","method":"siRNA/shRNA knockdown in A172 cells, in vitro migration/invasion assays, mouse xenograft model, western blotting for MMP2/MMP9 and macrophage markers","journal":"Journal of neuropathology and experimental neurology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, loss-of-function with phenotypic readout but limited mechanistic pathway resolution linking TWSG1 to MMP or macrophage polarization","pmids":["38950414"],"is_preprint":false}],"current_model":"TWSG1 is a secreted BMP signaling modulator that can act as a BMP antagonist by directly binding BMP ligands (including BMP2, BMP4, BMP6, BMP7) to block their receptor engagement, and as a context-dependent BMP agonist by neutralizing Chordin-family antagonists; in erythropoiesis it suppresses hepatocyte hepcidin expression through BMP2/BMP4 pathway inhibition, in early embryogenesis it restrains BMP activity required for forebrain and craniofacial midline patterning, and in cancer contexts it modulates cell proliferation, MMP expression, and macrophage polarization with the net outcome depending on BMP pathway activity in the specific tissue."},"narrative":{"mechanistic_narrative":"TWSG1 is a secreted modulator of BMP signaling that acts as a context-dependent antagonist or co-antagonist of BMP ligands [PMID:19414861, PMID:34517078]. It directly inhibits BMP signaling by binding and neutralizing BMP ligands, including BMP2 and BMP4 in hepatocytes [PMID:19414861] and BMP6 and BMP7 in bioactivity assays [PMID:34517078], and it additionally synergizes with the chordin subfamily, enhancing the BMP-antagonizing activity of CHRD and CHRDL1 against multiple BMP ligands, GDF5, and activin A [PMID:34517078]. Through suppression of BMP2/BMP4 signaling, TWSG1 represses hepcidin expression in hepatocytes, with both an indirect ligand-antagonism mechanism and an apparent BMP-independent component in murine cells [PMID:19414861]. In development, loss of Twsg1 sensitizes mouse embryos to retinoic acid-induced holoprosencephaly, consistent with TWSG1 normally restraining BMP2 signaling to protect forebrain patterning [PMID:25468951]. The molecular basis for TWSG1's dual agonist/antagonist behavior — and the structural details of its ligand and chordin interactions — has not been resolved in the available corpus.","teleology":[{"year":2009,"claim":"Established TWSG1 as a regulator of iron homeostasis by showing it suppresses hepcidin, linking a BMP modulator to erythropoietic iron control.","evidence":"Hepcidin qPCR suppression assays in human and murine hepatocytes with recombinant TWSG1, plus expression analysis in thalassemic mice","pmids":["19414861"],"confidence":"Medium","gaps":["BMP-independent component in murine cells not mechanistically defined","physiological source of TWSG1 acting on hepatocytes in vivo not established"]},{"year":2009,"claim":"Defined the mechanism of hepcidin suppression as TWSG1 antagonism of BMP2/BMP4 ligands, placing TWSG1 upstream in the BMP-hepcidin pathway.","evidence":"Hepcidin suppression assays with BMP2/BMP4 stimulation and TWSG1 co-treatment, qPCR readout","pmids":["19414861"],"confidence":"Medium","gaps":["direct binding affinities for BMP2/BMP4 not quantified","no structural data on the TWSG1-BMP interaction"]},{"year":2014,"claim":"Demonstrated a developmental role: TWSG1 restrains BMP2 signaling to protect forebrain midline patterning, with loss sensitizing embryos to teratogen-induced holoprosencephaly.","evidence":"Twsg1 knockout mouse model with RA gavage, micro-CT morphometrics, and P19 cell co-treatment with RA and BMP2 measuring p53/caspase/oxidative stress","pmids":["25468951"],"confidence":"Medium","gaps":["link between BMP-driven p53/caspase induction and the midline defect not directly demonstrated in vivo","does not establish whether the phenotype is purely BMP2-dependent"]},{"year":2021,"claim":"Resolved the dual nature of TWSG1: it independently antagonizes BMP6/BMP7 and also acts as a co-antagonist enhancing chordin-family inhibition of multiple ligands.","evidence":"Cell-based BMP/TGF-β reporter bioactivity assays with multiple ligands plus TWSG1, CHRD, and CHRDL1, and qPCR profiling in ovarian tissue","pmids":["34517078"],"confidence":"Medium","gaps":["does not define the conditions that switch TWSG1 between antagonist and co-antagonist modes","no mapping of ligand-binding versus chordin-binding interfaces"]},{"year":2018,"claim":"Extended TWSG1 function to cancer cell proliferation, showing context-dependent BMP-dependent and BMP-independent anti-proliferative effects in gastric cancer lines.","evidence":"TWSG1 overexpression with CCK-8 proliferation, flow cytometry cell cycle analysis, and BMP pathway western blots in gastric cancer cell lines","pmids":["29756996"],"confidence":"Low","gaps":["overexpression-only, limited mechanistic depth on BMP components","BMP-independent effect mechanism unidentified"]},{"year":2024,"claim":"Implicated TWSG1 as pro-tumorigenic in glioma, affecting invasion, MMP expression, and tumor-associated macrophage polarization.","evidence":"TWSG1 knockdown in A172 glioma cells, migration/invasion assays, xenograft model, MMP2/MMP9 and macrophage marker western blots","pmids":["38950414"],"confidence":"Low","gaps":["pathway linking TWSG1 to MMP expression and macrophage polarization not resolved","single cell line, no reciprocal validation of the BMP dependence"]},{"year":null,"claim":"The structural and biochemical basis for TWSG1's switch between direct BMP antagonism and chordin co-antagonism, and how this is tuned across tissues, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["no structural model of TWSG1-BMP or TWSG1-chordin complexes","determinants of context-dependent agonist versus antagonist output not defined","BMP-independent activities mechanistically uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,3]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[3]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,3]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,3]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2]}],"complexes":[],"partners":["BMP2","BMP4","BMP6","BMP7","CHRD","CHRDL1","GDF5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9GZX9","full_name":"Twisted gastrulation protein homolog 1","aliases":[],"length_aa":223,"mass_kda":25.0,"function":"May be involved in dorsoventral axis formation. Seems to antagonize BMP signaling by forming ternary complexes with CHRD and BMPs, thereby preventing BMPs from binding to their receptors. In addition to the anti-BMP function, also has pro-BMP activity, partly mediated by cleavage and degradation of CHRD, which releases BMPs from ternary complexes. May be an important modulator of BMP-regulated cartilage development and chondrocyte differentiation. May play a role in thymocyte development (By similarity)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q9GZX9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TWSG1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TWSG1","total_profiled":1310},"omim":[{"mim_id":"613127","title":"CHORDIN-LIKE 2; CHRDL2","url":"https://www.omim.org/entry/613127"},{"mim_id":"605049","title":"TWISTED GASTRULATION BMP MODULATOR 1; TWSG1","url":"https://www.omim.org/entry/605049"},{"mim_id":"604685","title":"HOMEOBOX A2; HOXA2","url":"https://www.omim.org/entry/604685"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Centrosome","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TWSG1"},"hgnc":{"alias_symbol":["TSG"],"prev_symbol":[]},"alphafold":{"accession":"Q9GZX9","domains":[{"cath_id":"-","chopping":"27-84","consensus_level":"medium","plddt":87.0622,"start":27,"end":84},{"cath_id":"-","chopping":"86-124_164-223","consensus_level":"medium","plddt":92.4468,"start":86,"end":223}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZX9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZX9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZX9-F1-predicted_aligned_error_v6.png","plddt_mean":80.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TWSG1","jax_strain_url":"https://www.jax.org/strain/search?query=TWSG1"},"sequence":{"accession":"Q9GZX9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9GZX9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9GZX9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZX9"}},"corpus_meta":[{"pmid":"19414861","id":"PMC_19414861","title":"Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19414861","citation_count":275,"is_preprint":false},{"pmid":"25468951","id":"PMC_25468951","title":"Impact of retinoic acid exposure on midfacial shape variation and manifestation of holoprosencephaly in Twsg1 mutant mice.","date":"2014","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/25468951","citation_count":17,"is_preprint":false},{"pmid":"21227728","id":"PMC_21227728","title":"Minimal evidence for a direct involvement of twisted gastrulation homolog 1 (TWSG1) gene in human holoprosencephaly.","date":"2010","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21227728","citation_count":10,"is_preprint":false},{"pmid":"36361543","id":"PMC_36361543","title":"Multifaceted Functions of TWSG1: From Embryogenesis to Cancer Development.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36361543","citation_count":8,"is_preprint":false},{"pmid":"29756996","id":"PMC_29756996","title":"TWSG1 Is a Novel Tumor Suppressor in Gastric Cancer.","date":"2018","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/29756996","citation_count":8,"is_preprint":false},{"pmid":"34517078","id":"PMC_34517078","title":"Expression profiling of ovarian BMP antagonists reveals the potential interaction between TWSG1 and the chordin subfamily in the ovary.","date":"2021","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34517078","citation_count":4,"is_preprint":false},{"pmid":"35958507","id":"PMC_35958507","title":"Hsa_circular RNA_0001013 exerts oncogenic effects in gastric cancer through the microRNA-136-TWSG1 axis.","date":"2022","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/35958507","citation_count":4,"is_preprint":false},{"pmid":"29654706","id":"PMC_29654706","title":"Arteriovenous specification: BMPER and TWSG1 determine endothelial cell fate via activation of synergistic BMP and Notch signaling.","date":"2018","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/29654706","citation_count":3,"is_preprint":false},{"pmid":"38950414","id":"PMC_38950414","title":"Research on the mechanism of TWSG1 in the malignant progression of glioma cells and tumor-associated macrophage infiltration.","date":"2024","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/38950414","citation_count":2,"is_preprint":false},{"pmid":"40302064","id":"PMC_40302064","title":"The Role of Twisted Gastrulation 1 (TWSG1) Gene in TGF-β Signaling Linked to Cancer: A Comprehensive Review.","date":"2025","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/40302064","citation_count":1,"is_preprint":false},{"pmid":"42011099","id":"PMC_42011099","title":"TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease.","date":"2026","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/42011099","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7506,"output_tokens":1874,"usd":0.025314,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8792,"output_tokens":2384,"usd":0.05178,"stage2_stop_reason":"end_turn"},"total_usd":0.077094,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"TWSG1 suppresses hepcidin expression in human hepatocyte cells by inhibiting BMP2/BMP4 signaling (indirect mechanism), and in murine hepatocytes it suppresses hepcidin even in the absence of exogenous BMP, suggesting an additional direct mechanism. Dose-dependent inhibition was demonstrated across 1–1000 ng/mL TWSG1.\",\n      \"method\": \"Hepcidin suppression assays (quantitative PCR), dosed treatment of hepatocyte cells with recombinant TWSG1 protein, in vivo expression analysis in thalassemic mice\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based functional assay with dose-response and in vivo corroboration, single lab but two orthogonal systems (human vs. murine cells)\",\n      \"pmids\": [\"19414861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TWSG1 interferes with BMP-mediated hepcidin upregulation by binding to/antagonizing BMP2 and BMP4 ligands, placing TWSG1 upstream of BMP signaling in the hepcidin regulation pathway.\",\n      \"method\": \"Hepcidin suppression assays with BMP2/BMP4 stimulation and TWSG1 co-treatment, quantitative PCR readout\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional cell-based assay with defined ligand-antagonism readout, single lab\",\n      \"pmids\": [\"19414861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Loss of Twsg1 (a BMP antagonist) sensitizes mouse embryos to retinoic acid-induced holoprosencephaly; in P19 cells, retinoic acid induces Bmp2 expression and acts synergistically with BMP2 to increase p53 expression, caspase activation, and oxidative stress, suggesting TWSG1 normally restrains BMP2 signaling to protect forebrain development.\",\n      \"method\": \"Genetic mouse model (Twsg1+/- and Twsg1-/- dams gavaged with RA), embryo microscopy, geometric morphometric micro-CT analysis, P19 cell culture with RA and BMP2 co-treatment, caspase activation and p53 immunoassays\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined developmental phenotype plus cell-based mechanistic follow-up, single lab\",\n      \"pmids\": [\"25468951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TWSG1 alone can directly inhibit BMP6 and BMP7 signaling in bioactivity assays. Additionally, TWSG1 enhances the antagonizing ability of Chordin (CHRD) against BMP2, BMP4, BMP7, and GDF5, and enhances CHRDL1 antagonism against BMP2, BMP4, GDF5, and activin A, demonstrating that TWSG1 can act as both an independent BMP antagonist and a co-antagonist synergizing with the chordin subfamily.\",\n      \"method\": \"Bioactivity assays measuring BMP/TGF-β signaling inhibition in cell-based reporter systems, quantitative PCR expression profiling in rat and human ovarian tissue\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional bioactivity assays with multiple BMP ligands and chordin family members, single lab\",\n      \"pmids\": [\"34517078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TWSG1 is described as acting as both a BMP agonist and antagonist: it inhibits BMP signaling by binding directly to BMP ligands (including BMP4), while it can enhance BMP signaling by interacting with Chordin (a BMP antagonist), thereby neutralizing Chordin's inhibitory effect.\",\n      \"method\": \"Literature synthesis with supporting experimental references (review article citing prior binding and functional assay data)\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — review article summarizing prior experimental results without presenting new primary data; no new experiment described\",\n      \"pmids\": [\"36361543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TWSG1 overexpression in gastric cancer cell lines (SGC-7901 and MGC-803) inhibited cell cycle progression and proliferation via regulation of BMP signaling, whereas in BGC-823 cells the anti-proliferative effect was independent of BMP signaling, indicating context-dependent mechanisms.\",\n      \"method\": \"CCK-8 proliferation assay, flow cytometry cell cycle analysis, western blotting for BMP pathway components in gastric cancer cell lines with TWSG1 overexpression\",\n      \"journal\": \"DNA and cell biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, overexpression with cell-based readout, limited mechanistic depth on BMP pathway components\",\n      \"pmids\": [\"29756996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Silencing TWSG1 in A172 glioma cells decreased cell viability, migration, and invasion in vitro and reduced tumor growth in vivo; it also reduced MMP2 and MMP9 expression, and shifted macrophage polarization from M2 toward M1 phenotype both in cell culture and tumor tissue.\",\n      \"method\": \"siRNA/shRNA knockdown in A172 cells, in vitro migration/invasion assays, mouse xenograft model, western blotting for MMP2/MMP9 and macrophage markers\",\n      \"journal\": \"Journal of neuropathology and experimental neurology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, loss-of-function with phenotypic readout but limited mechanistic pathway resolution linking TWSG1 to MMP or macrophage polarization\",\n      \"pmids\": [\"38950414\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TWSG1 is a secreted BMP signaling modulator that can act as a BMP antagonist by directly binding BMP ligands (including BMP2, BMP4, BMP6, BMP7) to block their receptor engagement, and as a context-dependent BMP agonist by neutralizing Chordin-family antagonists; in erythropoiesis it suppresses hepatocyte hepcidin expression through BMP2/BMP4 pathway inhibition, in early embryogenesis it restrains BMP activity required for forebrain and craniofacial midline patterning, and in cancer contexts it modulates cell proliferation, MMP expression, and macrophage polarization with the net outcome depending on BMP pathway activity in the specific tissue.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TWSG1 is a secreted modulator of BMP signaling that acts as a context-dependent antagonist or co-antagonist of BMP ligands [#1, #3]. It directly inhibits BMP signaling by binding and neutralizing BMP ligands, including BMP2 and BMP4 in hepatocytes [#1] and BMP6 and BMP7 in bioactivity assays [#3], and it additionally synergizes with the chordin subfamily, enhancing the BMP-antagonizing activity of CHRD and CHRDL1 against multiple BMP ligands, GDF5, and activin A [#3]. Through suppression of BMP2/BMP4 signaling, TWSG1 represses hepcidin expression in hepatocytes, with both an indirect ligand-antagonism mechanism and an apparent BMP-independent component in murine cells [#0, #1]. In development, loss of Twsg1 sensitizes mouse embryos to retinoic acid-induced holoprosencephaly, consistent with TWSG1 normally restraining BMP2 signaling to protect forebrain patterning [#2]. The molecular basis for TWSG1's dual agonist/antagonist behavior — and the structural details of its ligand and chordin interactions — has not been resolved in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 2009,\n      \"claim\": \"Established TWSG1 as a regulator of iron homeostasis by showing it suppresses hepcidin, linking a BMP modulator to erythropoietic iron control.\",\n      \"evidence\": \"Hepcidin qPCR suppression assays in human and murine hepatocytes with recombinant TWSG1, plus expression analysis in thalassemic mice\",\n      \"pmids\": [\"19414861\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"BMP-independent component in murine cells not mechanistically defined\", \"physiological source of TWSG1 acting on hepatocytes in vivo not established\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined the mechanism of hepcidin suppression as TWSG1 antagonism of BMP2/BMP4 ligands, placing TWSG1 upstream in the BMP-hepcidin pathway.\",\n      \"evidence\": \"Hepcidin suppression assays with BMP2/BMP4 stimulation and TWSG1 co-treatment, qPCR readout\",\n      \"pmids\": [\"19414861\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"direct binding affinities for BMP2/BMP4 not quantified\", \"no structural data on the TWSG1-BMP interaction\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated a developmental role: TWSG1 restrains BMP2 signaling to protect forebrain midline patterning, with loss sensitizing embryos to teratogen-induced holoprosencephaly.\",\n      \"evidence\": \"Twsg1 knockout mouse model with RA gavage, micro-CT morphometrics, and P19 cell co-treatment with RA and BMP2 measuring p53/caspase/oxidative stress\",\n      \"pmids\": [\"25468951\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"link between BMP-driven p53/caspase induction and the midline defect not directly demonstrated in vivo\", \"does not establish whether the phenotype is purely BMP2-dependent\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Resolved the dual nature of TWSG1: it independently antagonizes BMP6/BMP7 and also acts as a co-antagonist enhancing chordin-family inhibition of multiple ligands.\",\n      \"evidence\": \"Cell-based BMP/TGF-\\u03b2 reporter bioactivity assays with multiple ligands plus TWSG1, CHRD, and CHRDL1, and qPCR profiling in ovarian tissue\",\n      \"pmids\": [\"34517078\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"does not define the conditions that switch TWSG1 between antagonist and co-antagonist modes\", \"no mapping of ligand-binding versus chordin-binding interfaces\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended TWSG1 function to cancer cell proliferation, showing context-dependent BMP-dependent and BMP-independent anti-proliferative effects in gastric cancer lines.\",\n      \"evidence\": \"TWSG1 overexpression with CCK-8 proliferation, flow cytometry cell cycle analysis, and BMP pathway western blots in gastric cancer cell lines\",\n      \"pmids\": [\"29756996\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"overexpression-only, limited mechanistic depth on BMP components\", \"BMP-independent effect mechanism unidentified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Implicated TWSG1 as pro-tumorigenic in glioma, affecting invasion, MMP expression, and tumor-associated macrophage polarization.\",\n      \"evidence\": \"TWSG1 knockdown in A172 glioma cells, migration/invasion assays, xenograft model, MMP2/MMP9 and macrophage marker western blots\",\n      \"pmids\": [\"38950414\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"pathway linking TWSG1 to MMP expression and macrophage polarization not resolved\", \"single cell line, no reciprocal validation of the BMP dependence\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural and biochemical basis for TWSG1's switch between direct BMP antagonism and chordin co-antagonism, and how this is tuned across tissues, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"no structural model of TWSG1-BMP or TWSG1-chordin complexes\", \"determinants of context-dependent agonist versus antagonist output not defined\", \"BMP-independent activities mechanistically uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"BMP2\", \"BMP4\", \"BMP6\", \"BMP7\", \"CHRD\", \"CHRDL1\", \"GDF5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":4,"faith_pct":100.0}}